Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...

It's no secret that there is a mental health crisis in the United States. As of 2021, 8.3% of adults had major depressive ...

A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural ...

Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...

LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

and tolerability of Osavampator as an adjunctive treatment to antidepressants for patients with major depressive disorder or MDD. The company previously shared positive topline data from its Phase ...